FOUNDING MEMBER

Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients. Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation’s top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.

 

Katie Albert

Dr. Katie Albert's clinical interests are in pediatric oncology, pediatric sarcomas, and solid tumors, adolescent and young adult oncology. Her research interests are molecular targets in sarcomas and immunotherapy for pediatric solid tumors.

READ MORE

Academic Affiliations

Acting Assistant Professor

 

 

Colleen Annesley, MD

Attending Physician, Seattle Children’s

Dr. Colleen Annesley is an attending physician at Seattle Children's and an assistant professor of pediatrics at the University of Washington School of Medicine. Her research focuses on the development of novel immunotherapy trials for the treatment of pediatric leukemia and lymphoma. CAR T-cell immunotherapy has been a groundbreaking treatment for these diseases, and Dr. Annesley is working to improve this therapy even further, with the goal of providing a lasting cure for all children with this disease.

Dr. Annesley received an MD from Temple University School of Medicine. She completed her fellowship at Johns Hopkins Hospital and her pediatric residency at the University of Miami.

READ MORE

Academic Affiliations

Assistant Professor of Pediatrics, University of Washington School of Medicine

Associated Trials

NCT03186118

 

 

Rebecca A. Gardner, MD

Attending Physician, Seattle Children’s

Dr. Rebecca Gardner is an attending physician at Seattle Children's Cancer and Blood Disorders Center. She is also the associate medical director of Seattle Children’s Immunotherapy Coordinating Center, where she supports the implementation of cellular immunotherapies within CureWorks. In addition, Dr. Gardner is an assistant professor of pediatrics at the University of Washington School of Medicine.

Dr. Gardner’s research focuses on the development of immunotherapy trials for the treatment of pediatric leukemia and lymphoma. The trials involve genetically modifying a person's own T cells to allow the T cells to specifically recognize and kill cancer cells. Some of her earliest treated patients are still in remission after participating in a Seattle Children’s immunotherapy clinical trial for relapsed acute lymphoblastic leukemia.

READ MORE

Academic Affiliations

Assistant Professor of Pediatrics, University of Washington School of Medicine

Associated Trials

NCT02028455

NCT03330691

 

 

Juliane Gust, MD, PhD

Attending Physician, Seattle Children’s

Dr. Juliane Gust is an attending physician at Seattle Children’s and an acting instructor of pediatric neurology at the University of Washington School of Medicine. As a pediatric neurologist, Dr. Gust is interested in optimizing neurologic and developmental outcomes in children with cancer. She is currently working to better understand, prevent and treat neurologic side effects of CAR T-cell therapy for blood cancers, and on developing immunotherapies for pediatric brain tumors.

Dr. Gust received her PhD in developmental neurobiology and cellular therapy from the University of Washington, and completed her residency in child neurology at Seattle Children’s.

READ MORE

Academic Affiliations

Acting Instructor of Pediatric Neurology, University of Washington School of Medicine

 

 

 

 

Julie R. Park, MD

Attending Physician, Seattle Children’s

Bushnell, Towne and Wilkerson Endowed Chair in Pediatric Neuroblastoma

Dr. Julie Park is an attending physician at Seattle Children’s and the medical director of Seattle Children’s Immunotherapy Coordinating Center within the Immunotherapy Integration Hub, enabling the implementation of novel cellular immunotherapies within CureWorks. She is also a professor in pediatrics at the University of Washington School of Medicine and associate in the clinical research division at Fred Hutchinson Cancer Research Center.

Dr. Park’s research focus is on novel therapies for the treatment of high-risk neuroblastoma and refractory solid tumor malignancies. She has conducted a multi-center clinical trial to determine the feasibility and toxicity of a novel induction chemotherapy regimen for high risk neuroblastoma and has collaborated with national investigators to optimize the use of radiation therapy as part of treatment for neuroblastoma.

READ MORE

Academic Affiliations

Professor of Pediatrics, University of Washington School of Medicine

Associate, Clinical Research Division, Fred Hutchinson Cancer Research Center

Associated Trials

NCT02311621

 

 

Navin Robert Pinto, MD

Attending Physician, Seattle Children’s

Outpatient Medical Director for Cancer and Blood Disorders Center

Dr. Navin Pinto is an attending physician and the outpatient medial director for Seattle Children’s Cancer and Blood Disorders Center.

Dr. Pinto is dedicated to offering hope to children with complex solid malignancies, such as neuroblastoma and sarcoma, by providing access to promising and innovative therapies. He has worked extensively in the field of cancer pharmacogenomics – using a patient’s genetic code to predict sensitivity to a given treatment regimen.

He is involved in several phase 1 trials at Seattle Children’s to bring new treatments to the clinic. He is an active member of the Children’s Oncology Group (COG), the New Approaches to Neuroblastoma Therapy (NANT) and the Genomic Assessment Informing Novel Therapeutics (GAIN) consortia.

READ MORE

Academic Affiliations

Associate Professor of Pediatrics, University of Washington School of Medicine

 

 

Corinne Summers, MD

Principal Investigator, Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute

Dr. Corinne Summers is a principal investigator at Seattle Children’s Research Institute and an assistant professor at the University of Washington School of Medicine.

Dr. Summers’ research focuses on developing T-cell therapies targeting hematologic malignancies to prevent relapse following bone marrow transplant. More specifically, she is engineering T cells to target leukemia cells for infusion after transplant. The goal is to create engineered T cells that can kill residual leukemia cells to reduce the risk of post-transplant relapse.

Dr. Summers received an MD from Florida State University College of Medicine. She completed a general pediatric residency at Children's Hospital of Philadelphia and a pediatric hematology-oncology fellowship at Seattle Children’s and Fred Hutchinson Cancer Research Center.

READ MORE

Academic Affiliations

Assistant Professor, University of Washington School of Medicine

Associated Trials

NCT03244306

 

 

Nicholas Vitanza, MD

Attending Physician, Seattle Children’s

Dr. Nicholas Vitanza is a pediatric attending physician and neuro-oncologist at Seattle Children’s, and a laboratory researcher at Fred Hutchinson Cancer Research Center. He is also an assistant professor of pediatrics at the University of Washington School of Medicine.

During his residency at Stony Brook University, Dr. Vitanza became interested in pediatric oncology which combined both of his passions: working with critically ill children and participating in basic science research. He went on to do a fellowship in pediatric oncology at New York University, followed by a pediatric neuro-oncology fellowship at Stanford University. In 2016, he joined Seattle Children’s where he continues to care for children with brain and spinal cord tumors and conducts basic science research in collaboration with Dr. Michael Jensen.

READ MORE

Academic Affiliations

Assistant Professor of Pediatrics, University of Washington School of Medicine

Associated Trials

NCT03500991

 

 

For information about clinical trials in your area, please contact your child’s physician or visit clinicaltrials.gov

CureWorks™ is a trademark of Seattle Children’s
Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.

For information about clinical trials in your area, please contact your child’s physician or visit clinicaltrials.gov

CureWorks™ is a trademark of Seattle Children’s Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.

CureWorks logo A new way to better cures

CureWorks logo A new way to better cures

Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients. Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation’s top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.

 

Katie Albert

Dr. Katie Albert's clinical interests are in pediatric oncology, pediatric sarcomas, and solid tumors, adolescent and young adult oncology. Her research interests are molecular targets in sarcomas and immunotherapy for pediatric solid tumors.

READ MORE

Academic Affiliations

Acting Assistant Professor

 

 

Colleen Annesley, MD

Attending Physician, Seattle Children’s

Dr. Colleen Annesley is an attending physician at Seattle Children's and an assistant professor of pediatrics at the University of Washington School of Medicine. Her research focuses on the development of novel immunotherapy trials for the treatment of pediatric leukemia and lymphoma. CAR T-cell immunotherapy has been a groundbreaking treatment for these diseases, and Dr. Annesley is working to improve this therapy even further, with the goal of providing a lasting cure for all children with this disease.

Dr. Annesley received an MD from Temple University School of Medicine. She completed her fellowship at Johns Hopkins Hospital and her pediatric residency at the University of Miami.

READ MORE

Academic Affiliations

Assistant Professor of Pediatrics, University of Washington School of Medicine

Associated Trials

NCT03186118

 

 

Rebecca A. Gardner, MD

Attending Physician, Seattle Children’s

Dr. Rebecca Gardner is an attending physician at Seattle Children's Cancer and Blood Disorders Center. She is also the associate medical director of Seattle Children’s Immunotherapy Coordinating Center, where she supports the implementation of cellular immunotherapies within CureWorks. In addition, Dr. Gardner is an assistant professor of pediatrics at the University of Washington School of Medicine.

Dr. Gardner’s research focuses on the development of immunotherapy trials for the treatment of pediatric leukemia and lymphoma. The trials involve genetically modifying a person's own T cells to allow the T cells to specifically recognize and kill cancer cells. Some of her earliest treated patients are still in remission after participating in a Seattle Children’s immunotherapy clinical trial for relapsed acute lymphoblastic leukemia.

READ MORE

Academic Affiliations

Assistant Professor of Pediatrics, University of Washington School of Medicine

Associated Trials

NCT02028455

NCT03330691

 

 

Juliane Gust, MD, PhD

Attending Physician, Seattle Children’s

Dr. Juliane Gust is an attending physician at Seattle Children’s and an acting instructor of pediatric neurology at the University of Washington School of Medicine. As a pediatric neurologist, Dr. Gust is interested in optimizing neurologic and developmental outcomes in children with cancer. She is currently working to better understand, prevent and treat neurologic side effects of CAR T-cell therapy for blood cancers, and on developing immunotherapies for pediatric brain tumors.

Dr. Gust received her PhD in developmental neurobiology and cellular therapy from the University of Washington, and completed her residency in child neurology at Seattle Children’s.

READ MORE

Academic Affiliations

Acting Instructor of Pediatric Neurology, University of Washington School of Medicine

 

 

Julie R. Park, MD

Attending Physician, Seattle Children’s

Bushnell, Towne and Wilkerson Endowed Chair in Pediatric Neuroblastoma

Dr. Julie Park is an attending physician at Seattle Children’s and the medical director of Seattle Children’s Immunotherapy Coordinating Center within the Immunotherapy Integration Hub, enabling the implementation of novel cellular immunotherapies within CureWorks. She is also a professor in pediatrics at the University of Washington School of Medicine and associate in the clinical research division at Fred Hutchinson Cancer Research Center.

Dr. Park’s research focus is on novel therapies for the treatment of high-risk neuroblastoma and refractory solid tumor malignancies. She has conducted a multi-center clinical trial to determine the feasibility and toxicity of a novel induction chemotherapy regimen for high risk neuroblastoma and has collaborated with national investigators to optimize the use of radiation therapy as part of treatment for neuroblastoma.

READ MORE

Academic Affiliations

Professor of Pediatrics, University of Washington School of Medicine

Associate, Clinical Research Division, Fred Hutchinson Cancer Research Center

Associated Trials

NCT02311621

 

 

Navin Robert Pinto, MD

Attending Physician, Seattle Children’s

Outpatient Medical Director for Cancer and Blood Disorders Center

Dr. Navin Pinto is an attending physician and the outpatient medial director for Seattle Children’s Cancer and Blood Disorders Center.

Dr. Pinto is dedicated to offering hope to children with complex solid malignancies, such as neuroblastoma and sarcoma, by providing access to promising and innovative therapies. He has worked extensively in the field of cancer pharmacogenomics – using a patient’s genetic code to predict sensitivity to a given treatment regimen.

He is involved in several phase 1 trials at Seattle Children’s to bring new treatments to the clinic. He is an active member of the Children’s Oncology Group (COG), the New Approaches to Neuroblastoma Therapy (NANT) and the Genomic Assessment Informing Novel Therapeutics (GAIN) consortia.

READ MORE

Academic Affiliations

Associate Professor of Pediatrics, University of Washington School of Medicine

 

 

Corinne Summers, MD

Principal Investigator, Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute

Dr. Corinne Summers is a principal investigator at Seattle Children’s Research Institute and an assistant professor at the University of Washington School of Medicine.

Dr. Summers’ research focuses on developing T-cell therapies targeting hematologic malignancies to prevent relapse following bone marrow transplant. More specifically, she is engineering T cells to target leukemia cells for infusion after transplant. The goal is to create engineered T cells that can kill residual leukemia cells to reduce the risk of post-transplant relapse.

Dr. Summers received an MD from Florida State University College of Medicine. She completed a general pediatric residency at Children's Hospital of Philadelphia and a pediatric hematology-oncology fellowship at Seattle Children’s and Fred Hutchinson Cancer Research Center.

READ MORE

Academic Affiliations

Assistant Professor, University of Washington School of Medicine

Associated Trials

NCT03244306

 

 

Nicholas Vitanza, MD

Attending Physician, Seattle Children’s

Dr. Nicholas Vitanza is a pediatric attending physician and neuro-oncologist at Seattle Children’s, and a laboratory researcher at Fred Hutchinson Cancer Research Center. He is also an assistant professor of pediatrics at the University of Washington School of Medicine.

During his residency at Stony Brook University, Dr. Vitanza became interested in pediatric oncology which combined both of his passions: working with critically ill children and participating in basic science research. He went on to do a fellowship in pediatric oncology at New York University, followed by a pediatric neuro-oncology fellowship at Stanford University. In 2016, he joined Seattle Children’s where he continues to care for children with brain and spinal cord tumors and conducts basic science research in collaboration with Dr. Michael Jensen.

READ MORE

Academic Affiliations

Assistant Professor of Pediatrics, University of Washington School of Medicine

Associated Trials

NCT03500991

 

CureWorks logo A new way to better cures

CureWorks™ is a trademark of Seattle Children’s Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.